Get the Stockscreener App
2.69
8.03%
0.20
After Hours:
2.66
-0.03
-1.12%
Accuray Inc stock is traded at $2.69, with a volume of 2.98M.
It is up +8.03% in the last 24 hours and up +22.83% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$2.49
Open:
$2.6
24h Volume:
2.98M
Relative Volume:
4.23
Market Cap:
$270.52M
Revenue:
$447.48M
Net Income/Loss:
$-14.55M
P/E Ratio:
-17.93
EPS:
-0.15
Net Cash Flow:
$7.61M
1W Performance:
+15.95%
1M Performance:
+22.83%
6M Performance:
+79.33%
1Y Performance:
+4.26%
1-Day Range:
$2.57
$2.95
1-Week Range:
$2.15
$2.95
52-Week Range:
$1.40
$2.95
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
2.69 | 270.52M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray Inc (NASDAQ: ARAY): Blank Check On Growth? - Stocks Register
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript - Insider Monkey
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Prod - GuruFocus.com
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Product Revenue and Strategic ... - Yahoo Finance
Accuray raises FY 2025 revenue guidance to $463M-$475M, driven by strong China growth - MSN
Accuray Incorporated Shows Improved Financial Performance - TipRanks
Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates - MSN
Accuray: Fiscal Q2 Earnings Snapshot - Huron Daily Tribune
Accuray Inc Q2 Earnings: EPS of $0.03 Beats Estimate, Revenue Su - GuruFocus.com
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Accuray Q2 Earnings Summary & Key Takeaways - Benzinga
Accuray Reports Strong Q2 Financial Results for 2025 - TipRanks
Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q2 Revenue $116.2M, vs. FactSet Est of $110.3M - Marketscreener.com
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance - PR Newswire
Accuray Incorporated (NASDAQ:ARAY) Short Interest Up 12.3% in January - MarketBeat
Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex
A look into Accuray Inc (ARAY)’s deeper side - SETE News
Radiofrequency Ablation Devices For Pain Management Market - openPR
Here's Why You Should Add Accuray Stock in Your Portfolio Now - MSN
Non Melanoma Skin Cancer Market Expected to Reach $911.9 Million - openPR
With 61% ownership, Accuray Incorporated (NASDAQ:ARAY) boasts of strong institutional backing - Yahoo Finance
Accuray Incorporated (NASDAQ:ARAY) Shares Purchased by Assenagon Asset Management S.A. - Defense World
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product - PR Newswire
Accuray to Report Q2 FY2025 Financial Results on February 5Conference Call Details Announced - StockTitan
Accuray Hires Siemens Healthineers VP Leonel Peralta as COO - MPO-mag
Here's Why You Should Add Accuray Stock to Your Portfolio Now - MSN
Accuray (ARAY) to Release Earnings on Wednesday - MarketBeat
Accuray appoints new chief operations officer - MSN
Leonel Peralta to Join Accuray as Chief Operations Officer - PR Newswire
Global Radiation Oncology Treatment Planning Software Market - openPR
Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain Stock - MSN
Barclays PLC Acquires 104,310 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Fly 25% But Investors Aren't Buying For Growth - Simply Wall St
Radiotherapy Market Generated Opportunities, Future Scope by 2031 | Accuray Incorporated, Elekta , Isoray Inc. - EIN News
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions - Yahoo Finance
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System - PR Newswire
Why Accuray Incorporated (ARAY) Is Among the Cheap Robotics Stocks to Invest In Now? - Yahoo Finance
Accuray Secures Major China Approval for Revolutionary Cancer Treatment Systems - StockTitan
10 Cheap Robotics Stocks To Invest In Now - Insider Monkey
Jane Street Group LLC Grows Stock Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
EDAP Strengthens Board with Former Accuray CEO Josh Levine, Accelerating Robotic HIFU Growth - StockTitan
Geode Capital Management LLC Acquires 45,548 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO - Benzinga
Accuray – There’s Value If Linac Sales Accelerate, But That’s A Big “If” (NASDAQ:ARAY) - Seeking Alpha
Contrasting GlucoTrack (NASDAQ:GCTK) & Accuray (NASDAQ:ARAY) - Defense World
With Accuray Up 16%, Insider Buyers Count Their Returns - Simply Wall St
Radiotherapy Market Future Business Opportunities 2025-2032 | - openPR
Accuray (ARAY) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY) - Yahoo Finance
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):